Cascade-driven nanomotor with self-amplifying necrosis targeting and deep tumor penetration for enhanced type I photodynamic immunotherapy
Source abstract
Abstract
Cancer cells adjacent to the necrotic regions within deep-seated tumors exhibit elevated metastatic potential, while photodynamic immunotherapy, which utilizes photosensitizers as triggers to exert synergistic effects of photodynamic therapy (PDT) and anti-tumor immunotherapy, has attracted considerable interest. However, high oxygen dependency and complex biological barriers hinder the efficacy of nanomedicines by restricting reactive oxygen species generation and intratumoral penetration. Herein, a laser-triggered nanomotor (HCAT NPs) with self-amplifying necrosis targeting and deep tumor penetration is prepared for enhanced type I photodynamic immunotherapy. HCAT NPs can accumulate at the tumor site via targeting necrotic tissues, while recovered fluorescence emitted from hypericin can be used to self-monitor drug distribution and optimize laser exposure timing. Excitingly, Cu 2+ significantly enhances type I photosensitivity of hypericin by facilitating electron transfer and glutathione depletion, while cascade reactions triggered by the type I PDT induce the generation of nitric oxide, which synergistically promotes deep tumor penetration with hypericin via nanomotor propulsion and remodels vascular networks. Notably, the activated fluorescence emitted from TPE-4NM is utilized to self-report the generation of nitric oxide, while TPE-4NMB can eliminate peroxynitrite, which is related to tumor metastasis. The well-designed HCAT NPs demonstrate potent phototherapy effects against primary breast tumors, recurrences, and distant metastases, providing insight into the development of type I photosensitizers and novel cascade reaction-driven precision strategies for deep tumor ablation. • HCAT was self-assembled for enhanced type I photodynamic immunotherapy. • Cu 2+ enhanced type I photosensitivity of HPC via electron transfer & GSH depletion. • Cascade reactions triggered by PDT enable imaging-guided NO generation. • HCAT enables deep tumor penetration via NO propulsion and necrotic targeting.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Micro and Nano Robotics · Nanoplatforms for cancer theranostics · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
2. Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies10.1039/D0CS01370F ↗
3. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy10.7150/thno.67300 ↗
4. How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?10.7150/thno.72465 ↗
5. An activatable phototheranostic probe for anti‐hypoxic type I Photodynamic‐ and immuno‐therapy of cancer10.1002/adma.202305243 ↗
6. Paraptosis inducer to effectively trigger immunogenic cell death for metastatic tumor immunotherapy with IDO inhibition10.1021/acsnano.2c11964 ↗
7. Plasma membrane targeted photodynamic nanoagonist to potentiate immune checkpoint blockade therapy by initiating tumor cell pyroptosis and depleting infiltrating B cells10.1002/adma.202415078 ↗
8. Potent covalent organic framework nanophotosensitizers with staggered type I/II motifs for photodynamic immunotherapy of hypoxic tumors10.1021/acsnano.4c14555 ↗
9. Nitric oxide‐driven nanomotor for deep tissue penetration and multidrug resistance reversal in cancer therapy10.1002/advs.202002525 ↗
10. Supramolecular nitric oxide depot for hypoxic tumor vessel normalization and radiosensitization10.1002/adma.202202625 ↗
11. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review10.2217/fon.11.99 ↗
12. Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renal, lung, thyroid and colorectal carcinomas: a brief review10.3892/ol.2011.420 ↗
13. Neutrophils drive vascular occlusion, tumour necrosis and metastasis10.1038/s41586-025-09278-3 ↗
14. The revolution of type I organic photosensitizers: current strategies and future directions10.1016/j.scib.2025.02.037 ↗
15. New guidelines and definitions for type I photodynamic therapy10.1039/D1CS01079D ↗
16. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing10.1038/nmeth761 ↗
17. Deep penetration of nanolevel drugs and micrometer-level T cells promoted by nanomotors for cancer immunochemotherapy10.1021/jacs.1c03071 ↗
18. Polyoxometalate‐Nanozyme‐Integrated nanomotors (POMotors) for self‐propulsion‐promoted synergistic photothermal‐catalytic tumor therapy10.1002/anie.202315031 ↗
19. Glucose-Fueled gated nanomotors: enhancing in vivo anticancer efficacy via deep drug penetration into tumors10.1021/acsnano.5c03799 ↗
20. Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy10.1038/s41467-024-54293-z ↗
21. Enzymatic nanomotors with chemotaxis for product-based cancer therapy
22. Nanogel-based nitric oxide-driven nanomotor for deep tissue penetration and enhanced tumor therapy10.1016/j.jconrel.2024.06.021 ↗
23. NIR‐Actuated ferroptosis nanomotor for enhanced tumor penetration and therapy
24. Activatable enzymatic nanoplatform incorporated into microneedle patch for relieving tumor Hypoxia augmented photodynamic therapy
25. An activatable theranostic nanoprobe for dual-modal imaging-guided photodynamic therapy with self-reporting of sensitizer activation and therapeutic effect10.1021/acsnano.0c10916 ↗
26. Electron transfer mediator modulates type II porphyrin-based metal-organic framework photosensitizers for type I photodynamic therapy10.1002/anie.202420643 ↗
27. A regioselectively oxidized 2D Bi/BiOx lateral nano‐heterostructure for hypoxic photodynamic therapy10.1002/adma.202102562 ↗
28. Antibacterial carbon‐based nanomaterials10.1002/adma.201804838 ↗
29. Type I photosensitizer targeting G-Quadruplex RNA elicits augmented immunity for cancer ablation10.1002/anie.202300162 ↗
30. Photo-generating Type-I ROS and aryl radicals by mitochondrial-targeting oxime-ester photogenerator for pyroptosis-mediated anti-hypoxia photoimmunotherapy
31. Cationization to boost both type I and type II ROS generation for photodynamic therapy10.1016/j.biomaterials.2021.121255 ↗
32. Electron-Withdrawing substituents enhance the type I PDT and NIR-II fluorescence of BODIPY J aggregates for bioimaging and cancer therapy10.1021/acs.nanolett.4c01339 ↗
33. Thymoquinone as an electron transfer mediator to convert Type II photosensitizers to Type I photosensitizers10.1038/s41467-024-49311-z ↗
34. A novel nanomedicine for osteosarcoma treatment: triggering ferroptosis through GSH depletion and inhibition for enhanced synergistic PDT/PTT therapy10.1186/s12951-025-03380-4 ↗
35. Enhanced photodynamic therapy by reduced levels of intracellular glutathione obtained by employing a Nano-MOF with Cu (II) as the active Center10.1002/anie.201710800 ↗
36. Hyaluronic acid-coated porphyrin nanoplatform with oxygen sustained supplying and glutathione depletion for enhancing photodynamic/ion/chemo synergistic cancer treatment
37. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy10.7150/thno.28344 ↗
38. Self-Delivered and self-monitored chemo-photodynamic nanoparticles with light-triggered synergistic antitumor therapies by downregulation of HIF-1α and depletion of GSH10.1021/acsami.9b23325 ↗
39. Simultaneous visualization and depletion of peroxynitrite by a simple aggregation-induced emission nanoprobe for preventing breast cancer metastasis after surgery10.1021/acs.analchem.3c05292 ↗
40. Oxygen and heat Dual‐Driven Stomatocyte nanomotors for highly efficient inflammation‐relieved breast tumor photothermal therapy
41. Natural products from herbal medicine self‐assemble into advanced bioactive materials10.1002/advs.202403388 ↗
42. Accessible and effective nanomedicines: self-assembly products from Chinese herbal medicines (CHMs)10.1002/adfm.202416151 ↗
43. A self-amplified necrotic targeting theranostic nanoparticle with deep tumor penetration for imaging-guided personalized chemo-photodynamic therapy
44. Delivery of hypericin for photodynamic applications10.1016/j.canlet.2005.10.020 ↗
45. Orchestrated metal-coordinated carrier-free celastrol hydrogel intensifies T cell activation and regulates response to immune checkpoint blockade for synergistic chemo-immunotherapy10.1016/j.biomaterials.2024.122723 ↗
46. Continuous spatiotemporal therapy of a Full-API nanodrug via multi-step tandem endogenous biosynthesis10.1038/s41467-023-37315-0 ↗
47. Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy10.1016/j.ccell.2022.09.001 ↗
48. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation10.1074/jbc.M102417200 ↗
49. Nitric oxide and peroxynitrite in health and disease10.1152/physrev.00029.2006 ↗
50. Biodegradable hypericin-containing nanoparticles for necrosis targeting and fluorescence imaging10.1021/acs.molpharmaceut.9b01238 ↗
51. Novel carrier‐free nanomedicine for regulating macrophage phenotype to amplify anti‐tumor photoimmunotherapy10.1002/smll.202505304 ↗
52. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies10.1038/s41565-019-0570-3 ↗